PUBLISHER: Grand View Research | PRODUCT CODE: 2040440
PUBLISHER: Grand View Research | PRODUCT CODE: 2040440
The global oligonucleotide synthesis reagents market size was estimated at USD 723.3 million in 2025 and is projected to reach USD 1751.3 million by 2033, growing at a CAGR of 11.9% from 2026 to 2033. The growth is driven by increasing demand for oligonucleotide-based therapeutics, expanding applications in diagnostics and genomics, and advancements in DNA/RNA synthesis technologies.
Rapid growth of nucleic acid-based therapeutics
The rapid growth of nucleic acid-based therapeutics is a key driver of the oligonucleotide synthesis reagents market, as these therapies depend on synthetic oligonucleotides as core components. Modalities such as siRNA, antisense oligonucleotides (ASOs), CRISPR-based gene editing, and mRNA platforms are increasingly targeting previously undruggable pathways, with multiple approved therapies and a growing pipeline across oncology, rare genetic disorders, and infectious diseases. This expansion is driving demand for high-quality oligonucleotide production and, consequently, increasing consumption of synthesis reagents from research through commercialization.
Global Oligonucleotide Synthesis Reagents Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the oligonucleotide synthesis reagents market report based on product, application, end use, and region: